Menu

Annual Report 2015

STRONGER

To our Shareholders

“Today, our company is better positioned than ever before. We can be proud of what our is today: a leading science and technology company whose ideas and products can -really make a difference in the world. With our three business sectors Healthcare, Life Science and Perform-ance Materials, we are not only successful, but also improve the lives of patients, customers and partners all over the world.”

Karl-Ludwig Kley
Chairman of the Executive Board

More

Magazine

A CLEAR
VIEW

We are working to develop future-oriented products, such as an ingenious artificial eye lens in which liquid crystal technology is used.

More

READY FOR
PRINTING

OLED displays offer captivating advantages, whether for smartphones or large televisions. With innovative printing processes, we want to play a pioneering role in this field.

More

PROGRESS

Immuno-oncological therapies represent a new era in cancer treatment. Together with Pfizer we aim to unlock the potential of this area of research through a strategic alliance.

More

AWARE
NESS

With its Capacity Advancement Program, we aim to strengthen its education and prevention efforts among people living in developing countries. The focus is on diabetes, cancer and fertility treatment.

More

GROWTH

Having completed the acquisition of Sigma-Aldrich, we are now one of the leading players in the global life science industry – and also have a superb e-commerce platform.

More

A CLEAR
VIEW

We are working to develop future-oriented products, such as an ingenious artificial eye lens in which liquid crystal technology is used.

More

READY FOR
PRINTING

OLED displays offer captivating advantages, whether for smartphones or large televisions. With innovative printing processes, we want to play a pioneering role in this field.

More

PROGRESS

Immuno-oncological therapies represent a new era in cancer treatment. Together with Pfizer we aim to unlock the potential of this area of research through a strategic alliance.

More

AWARE
NESS

With its Capacity Advancement Program, we aim to strengthen its education and prevention efforts among people living in developing countries. The focus is on diabetes, cancer and fertility treatment.

More

GROWTH

Having completed the acquisition of Sigma-Aldrich, we are now one of the leading players in the global life science industry – and also have a superb e-commerce platform.

More